Funded Startups in Carlsbad
The largest disclosed round on this Carlsbad-focused list is Rapalogix Health’s $20M Series A dated 2026-06-23; it sits in the same upper band as a few oth…
The largest disclosed round on this Carlsbad-focused list is Rapalogix Health’s $20M Series A dated 2026-06-23; it sits in the same upper band as a few other disclosed rounds (for example Nalu Medical’s $50M on 2025-09-15 and Allez Health’s $60M on 2024-05-22), but the overall distribution is dominated by smaller disclosed figures like LenderSquared’s $340K (2025-10-17) and multiple $2M–$12M rounds. Outliers are also visible at the low end: Oral Genome’s $80K round dated 2022-11-23 is the smallest disclosed amount, while other large disclosed entries cluster well above $30M (e.g., SeaSpine $30M in 2022-07-19; Airspace $70M in 2022-05-25). The rounds span from 2026-06-24 back to 2020-12-07 across 49 rows, with the most recent entry being Oral Genome (Seed, $50K) on 2026-06-24.
Sectors repeat enough to form clusters: Biotechnology is the most frequent category in the listing (appearing in multiple dated rounds such as Rapalogix Health 2026-06-23, Palisade Bio 2026-01-07, Lineage Cell Therapeutics 2025-08-26, and Allez Health 2024-05-22). Stage visibility is uneven: “Series Unknown” appears repeatedly (including 2026-06-23 ALT Sports Data at $5M and 2026-05-26 Proper Voltage at $7M), and “undisclosed” amounts show up as a recurring placeholder (e.g., Cubit on 2026-05-07; Kato Medical on 2026-04-05; Oral Genome appears again later, but not as undisclosed).
Most recent rounds
49 shownRelated listings
Frequently asked
What does the upper end of disclosed funding look like in Carlsbad, and which entries set the pace?
The largest disclosed amount is Allez Health’s $60M (Series A) dated 2024-05-22, and it is followed by other high disclosed rounds such as Airspace’s $70M (Series D) on 2022-05-25 and SeaSpine’s $30M (Post-IPO Debt) on 2022-07-19. Compared with the many $2M–$12M disclosed figures (e.g., Challenger $3M in 2022-03-07; View Point Medical $4M in 2024-01-23), these $30M+ rounds stand out as the clear upper band.
Is there a time concentration in the most recent part of this list?
Yes. Multiple rounds fall within the last 90 days of the dataset’s most recent date (2026-06-24), including Oral Genome ($50K) on 2026-06-24, ALT Sports Data ($5M) on 2026-06-23, and both Rapalogix Health ($20M) and Proper Voltage ($7M) in late June 2026. Earlier years also show bursts, such as 2024-01 with several disclosed rounds (Palisade Bio $500K on 2026-01-07 is later; for 2024-01 itself: View Point Medical $4M on 2024-01-23 and Preemadonna $310K on 2024-01-01).
Which sectors are over-represented in this Carlsbad batch?
Biotechnology is repeatedly represented across years (e.g., Rapalogix Health 2026-06-23 at $20M; Lineage Cell Therapeutics 2025-08-26 at $12M; Biora Therapeutics 2024-10-29 at $3M; Allez Health 2024-05-22 at $60M). Other categories appear, but not with the same apparent frequency in the rows shown.
How much of the funding picture is obscured by “Series Unknown” and “undisclosed” amounts?
Stage and amount disclosure are inconsistent. “Series Unknown” appears on many entries (for example ALT Sports Data on 2026-06-23 at $5M and Proper Voltage on 2026-05-26 at $7M), and “undisclosed” amounts recur as well (Cubit on 2026-05-07; Kato Medical on 2026-04-05; Okika Devices Corporation on 2025-08-28; ALZpath on 2023-07-18). This means rankings by amount are limited to disclosed rows.
Are there notable low-end outliers in disclosed round sizes?
Oral Genome’s $80K (Series Unknown) on 2022-11-23 is the smallest disclosed amount in the list, noticeably below the next disclosed levels that cluster in the $2M–$8M range (e.g., Deal Box $2M on 2020-12-07; AppTech Payments Corp. $4M on 2023-10-24; Loyal Foundry $4M on 2023-03-17).
Which stages appear most often with disclosed amounts, and where are the clearest examples?
Early-stage labels like Seed and later disclosed “Series” labels both occur, but several large rounds are associated with specific named stages: Allez Health is explicitly Series A at $60M on 2024-05-22, while Nalu Medical is labeled Venture - Series Unknown at $50M on 2025-09-15 and GigaIO is labeled Series B at $21M on 2025-07-17. Meanwhile, many entries use “Series Unknown” even when amounts are disclosed (e.g., Ceresti Health $10M on 2026-05-11 and ImpediMed $11M on 2026-05-04).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.